| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | DRD1 DRD4 DRD5 NPY6R MRGPRD OR5B12 OR13C5 MC1R OR5B17 MC3R OR5K3 VN1R17P GRM1 GRM8 OR10X1 OR13J1 OR52B4 OR1I1 FBXW7-AS1 ADGRF3 | 1.08e-07 | 884 | 113 | 20 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SCN11A SLC52A1 ATP7B SLC7A13 SLC22A23 SLC43A1 SLC28A3 KCNK13 SLC25A25 CLDN2 SLC6A1 SLC6A6 SLCO5A1 SLC7A4 SLC12A4 SLC16A14 UCP3 ABCB8 SLC28A2 SLC35F2 SLC16A7 KCNT1 | 6.47e-07 | 1180 | 113 | 22 | GO:0022857 |
| GeneOntologyMolecularFunction | dopamine neurotransmitter receptor activity | 1.75e-06 | 5 | 113 | 3 | GO:0004952 | |
| GeneOntologyMolecularFunction | transporter activity | SCN11A SLC52A1 ATP7B SLC7A13 SLC22A23 SLC43A1 SLC28A3 KCNK13 SLC25A25 CLDN2 SLC6A1 SLC6A6 SLCO5A1 SLC7A4 SLC12A4 SLC16A14 UCP3 ABCB8 SLC28A2 SLC35F2 SLC16A7 KCNT1 | 2.79e-06 | 1289 | 113 | 22 | GO:0005215 |
| GeneOntologyMolecularFunction | dopamine binding | 6.08e-06 | 7 | 113 | 3 | GO:0035240 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | DRD1 DRD4 DRD5 NPY6R MRGPRD OR5B12 OR13C5 MC1R OR5B17 MC3R OR5K3 VN1R17P GRM1 GRM8 OR10X1 OR13J1 OR52B4 OR1I1 LMBR1L FBXW7-AS1 FGFR1 ADGRF3 | 6.09e-06 | 1353 | 113 | 22 | GO:0004888 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC7A13 SLC28A3 SLC25A25 SLC6A1 SLC6A6 SLCO5A1 SLC12A4 SLC16A14 SLC28A2 SLC16A7 | 7.12e-06 | 296 | 113 | 10 | GO:0015291 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ATP7B SLC7A13 SLC28A3 SLC25A25 SLC6A1 SLC6A6 SLCO5A1 SLC12A4 SLC16A14 ABCB8 SLC28A2 SLC16A7 | 1.67e-05 | 477 | 113 | 12 | GO:0022804 |
| GeneOntologyMolecularFunction | symporter activity | 2.33e-05 | 150 | 113 | 7 | GO:0015293 | |
| GeneOntologyMolecularFunction | dopamine neurotransmitter receptor activity, coupled via Gs | 3.17e-05 | 2 | 113 | 2 | GO:0001588 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC52A1 SLC7A13 SLC43A1 SLC25A25 SLC6A1 SLC6A6 SLCO5A1 SLC16A14 SLC16A7 | 4.39e-05 | 293 | 113 | 9 | GO:0008514 |
| GeneOntologyMolecularFunction | catecholamine binding | 4.84e-05 | 13 | 113 | 3 | GO:1901338 | |
| GeneOntologyMolecularFunction | melanocyte-stimulating hormone receptor activity | 9.49e-05 | 3 | 113 | 2 | GO:0004980 | |
| GeneOntologyMolecularFunction | secondary active monocarboxylate transmembrane transporter activity | 1.60e-04 | 19 | 113 | 3 | GO:0015355 | |
| GeneOntologyMolecularFunction | nucleoside:sodium symporter activity | 1.89e-04 | 4 | 113 | 2 | GO:0005415 | |
| GeneOntologyMolecularFunction | nucleobase:monoatomic cation symporter activity | 1.89e-04 | 4 | 113 | 2 | GO:0015391 | |
| GeneOntologyMolecularFunction | pyrimidine- and adenosine-specific:sodium symporter activity | 1.89e-04 | 4 | 113 | 2 | GO:0015389 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 2.88e-04 | 23 | 113 | 3 | GO:0015377 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SCN11A ATP7B SLC28A3 KCNK13 SLC6A1 SLC6A6 SLC12A4 UCP3 SLC28A2 KCNT1 | 3.11e-04 | 465 | 113 | 10 | GO:0046873 |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 3.27e-04 | 105 | 113 | 5 | GO:0015171 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 4.17e-04 | 26 | 113 | 3 | GO:0015296 | |
| GeneOntologyMolecularFunction | uridine transmembrane transporter activity | 4.69e-04 | 6 | 113 | 2 | GO:0015213 | |
| GeneOntologyMolecularFunction | gamma-aminobutyric acid:sodium:chloride symporter activity | 4.69e-04 | 6 | 113 | 2 | GO:0005332 | |
| GeneOntologyMolecularFunction | melanocortin receptor activity | 4.69e-04 | 6 | 113 | 2 | GO:0004977 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 5.81e-04 | 119 | 113 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | pyrimidine nucleobase transmembrane transporter activity | 6.54e-04 | 7 | 113 | 2 | GO:0005350 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 8.67e-04 | 75 | 113 | 4 | GO:0098960 | |
| GeneOntologyMolecularFunction | pyrimidine nucleoside transmembrane transporter activity | 8.69e-04 | 8 | 113 | 2 | GO:0015214 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 1.11e-03 | 9 | 113 | 2 | GO:0098988 | |
| GeneOntologyMolecularFunction | gamma-aminobutyric acid transmembrane transporter activity | 1.11e-03 | 9 | 113 | 2 | GO:0015185 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 1.11e-03 | 9 | 113 | 2 | GO:0001640 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 1.16e-03 | 81 | 113 | 4 | GO:0015370 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.16e-03 | 207 | 113 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.19e-03 | 208 | 113 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | purine nucleobase transmembrane transporter activity | 1.39e-03 | 10 | 113 | 2 | GO:0005345 | |
| GeneOntologyMolecularFunction | nucleoside transmembrane transporter activity | 1.39e-03 | 10 | 113 | 2 | GO:0005337 | |
| GeneOntologyMolecularFunction | nucleobase transmembrane transporter activity | 1.69e-03 | 11 | 113 | 2 | GO:0015205 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.71e-03 | 90 | 113 | 4 | GO:0008028 | |
| GeneOntologyMolecularFunction | CCR1 chemokine receptor binding | 2.02e-03 | 12 | 113 | 2 | GO:0031726 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 2.51e-03 | 100 | 113 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | hormone binding | 2.80e-03 | 103 | 113 | 4 | GO:0042562 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.90e-03 | 171 | 113 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SCN11A ATP7B SLC28A3 KCNK13 SLC6A1 SLC6A6 SLC12A4 UCP3 SLC28A2 KCNT1 | 2.97e-03 | 627 | 113 | 10 | GO:0022890 |
| GeneOntologyMolecularFunction | olfactory receptor activity | 3.14e-03 | 431 | 113 | 8 | GO:0004984 | |
| GeneOntologyMolecularFunction | monocarboxylate:sodium symporter activity | 3.18e-03 | 15 | 113 | 2 | GO:0140161 | |
| GeneOntologyMolecularFunction | chemoattractant activity | 3.55e-03 | 54 | 113 | 3 | GO:0042056 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SCN11A ATP7B SLC28A3 KCNK13 SLC25A25 SLC6A1 SLC6A6 SLC12A4 UCP3 SLC28A2 KCNT1 | 3.80e-03 | 758 | 113 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 4.08e-03 | 17 | 113 | 2 | GO:0015378 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 4.22e-03 | 268 | 113 | 6 | GO:0005539 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SCN11A ATP7B SLC28A3 KCNK13 SLC6A1 SLC6A6 SLC12A4 UCP3 SLC28A2 KCNT1 | 4.44e-03 | 664 | 113 | 10 | GO:0008324 |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 4.56e-03 | 59 | 113 | 3 | GO:1901505 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 4.56e-03 | 59 | 113 | 3 | GO:0015932 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 4.58e-03 | 18 | 113 | 2 | GO:0030169 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 5.10e-03 | 19 | 113 | 2 | GO:0015373 | |
| GeneOntologyMolecularFunction | sialyltransferase activity | 6.21e-03 | 21 | 113 | 2 | GO:0008373 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | SCN11A DRD1 DRD4 DRD5 NPY6R MRGPRD OR5B12 OR13C5 MC1R OR5B17 MC3R OR5K3 VN1R17P GRM1 GRM8 OR10X1 OR13J1 ADCY9 OR52B4 OR1I1 FBXW7-AS1 ADGRF3 CCL18 CCL23 | 4.36e-07 | 1395 | 113 | 24 | GO:0007186 |
| GeneOntologyBiologicalProcess | organic anion transport | DRD4 SLC52A1 SLC7A13 FOLR2 SLC43A1 GRM1 SLC25A25 SLC6A1 SLC6A6 SLCO5A1 THBS1 SLC16A14 SLC16A7 | 4.97e-06 | 515 | 113 | 13 | GO:0015711 |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 2.83e-05 | 286 | 113 | 9 | GO:0007188 | |
| GeneOntologyBiologicalProcess | sensory perception | SCN11A MYO5A OR5B12 OR13C5 MC1R OR5B17 OR5K3 VN1R17P DRAM2 GRM1 GRM8 OR10X1 OR13J1 OR52B4 OR1I1 FGFR1 TACSTD2 | 7.33e-05 | 1072 | 113 | 17 | GO:0007600 |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission | 7.83e-05 | 80 | 113 | 5 | GO:0050805 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | DRD4 SLC7A13 FOLR2 SLC43A1 GRM1 SLC6A1 SLC6A6 THBS1 SLC16A14 SLC16A7 | 8.68e-05 | 410 | 113 | 10 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | DRD4 SLC7A13 FOLR2 SLC43A1 GRM1 SLC6A1 SLC6A6 THBS1 SLC16A14 SLC16A7 | 9.03e-05 | 412 | 113 | 10 | GO:0015849 |
| GeneOntologyCellularComponent | GABA-ergic synapse | 3.75e-06 | 164 | 116 | 8 | GO:0098982 | |
| GeneOntologyCellularComponent | postsynaptic membrane | VWC2 DRD1 DRD4 DRD5 GRM1 SLC6A1 GRIP1 SLC6A6 SLC16A7 KCNT1 CDH10 | 1.60e-05 | 405 | 116 | 11 | GO:0045211 |
| GeneOntologyCellularComponent | synaptic membrane | VWC2 SCN11A DRD1 DRD4 DRD5 GRM1 GRM8 SLC6A1 GRIP1 SLC6A6 SLC16A7 KCNT1 CDH10 | 2.15e-05 | 583 | 116 | 13 | GO:0097060 |
| GeneOntologyCellularComponent | presynaptic membrane | 1.59e-04 | 277 | 116 | 8 | GO:0042734 | |
| GeneOntologyCellularComponent | glutamatergic synapse | VWC2 SCN11A DRD1 DRD4 DRD5 MYO5A TSC2 GRM1 GRM8 GRIP1 PPP2R1B FGFR1 SLC16A7 CDH10 | 1.75e-04 | 817 | 116 | 14 | GO:0098978 |
| GeneOntologyCellularComponent | postsynapse | VWC2 DRD1 DRD4 DRD5 MYO5A TSC2 GRM1 SLC6A1 GRIP1 SLC6A6 FGF7 FGFR1 SLC16A7 KCNT1 CDH10 | 5.10e-04 | 1018 | 116 | 15 | GO:0098794 |
| GeneOntologyCellularComponent | dendritic spine neck | 1.07e-03 | 9 | 116 | 2 | GO:0044326 | |
| GeneOntologyCellularComponent | G protein-coupled receptor complex | 1.63e-03 | 11 | 116 | 2 | GO:0097648 | |
| Domain | Dopamine_rcpt | 1.97e-06 | 5 | 110 | 3 | IPR000929 | |
| Domain | ARM-like | MROH2A RTTN XPO4 TSC2 HEATR5A WDFY4 PPP2R1B MROH1 TTC12 MROH7 | 4.45e-06 | 270 | 110 | 10 | IPR011989 |
| Domain | - | 6.61e-06 | 222 | 110 | 9 | 1.25.10.10 | |
| Domain | ARM-type_fold | MROH2A RTTN XPO4 TSC2 HEATR5A WDFY4 PPP2R1B MROH1 TTC12 MROH7 | 3.20e-05 | 339 | 110 | 10 | IPR016024 |
| Domain | GPCR_Rhodpsn_7TM | DRD1 DRD4 DRD5 MRGPRD OR5B12 OR13C5 MC1R OR5B17 MC3R OR5K3 OR10X1 OR13J1 OR52B4 OR1I1 | 3.90e-05 | 670 | 110 | 14 | IPR017452 |
| Domain | 7tm_1 | DRD1 DRD4 DRD5 MRGPRD OR5B12 OR13C5 MC1R OR5B17 MC3R OR5K3 OR10X1 OR13J1 OR52B4 OR1I1 | 4.37e-05 | 677 | 110 | 14 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | DRD1 DRD4 DRD5 MRGPRD OR5B12 OR13C5 MC1R OR5B17 MC3R OR5K3 OR10X1 OR13J1 OR52B4 OR1I1 | 4.96e-05 | 685 | 110 | 14 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | DRD1 DRD4 DRD5 MRGPRD OR5B12 OR13C5 MC1R OR5B17 MC3R OR5K3 OR10X1 OR13J1 OR52B4 OR1I1 | 5.45e-05 | 691 | 110 | 14 | PS50262 |
| Domain | GPCR_Rhodpsn | DRD1 DRD4 DRD5 MRGPRD OR5B12 OR13C5 MC1R OR5B17 MC3R OR5K3 OR10X1 OR13J1 OR52B4 OR1I1 | 5.53e-05 | 692 | 110 | 14 | IPR000276 |
| Domain | HEAT_REPEAT | 5.77e-05 | 70 | 110 | 5 | PS50077 | |
| Domain | CNT_N_dom | 1.03e-04 | 3 | 110 | 2 | IPR002668 | |
| Domain | C_nuclsd_transpt | 1.03e-04 | 3 | 110 | 2 | IPR008276 | |
| Domain | CNT_C_dom | 1.03e-04 | 3 | 110 | 2 | IPR011657 | |
| Domain | C_nuclsd_transpt_met_bac | 1.03e-04 | 3 | 110 | 2 | IPR018270 | |
| Domain | Gate_dom | 1.03e-04 | 3 | 110 | 2 | IPR011642 | |
| Domain | Nucleos_tra2_N | 1.03e-04 | 3 | 110 | 2 | PF01773 | |
| Domain | Nucleos_tra2_C | 1.03e-04 | 3 | 110 | 2 | PF07662 | |
| Domain | Gate | 1.03e-04 | 3 | 110 | 2 | PF07670 | |
| Domain | AA-permease/SLC12A_dom | 2.82e-04 | 22 | 110 | 3 | IPR004841 | |
| Domain | AA_permease | 2.82e-04 | 22 | 110 | 3 | PF00324 | |
| Domain | Melcrt_ACTH_rcpt | 5.08e-04 | 6 | 110 | 2 | IPR001671 | |
| Domain | 7TM_GPCR_Srsx | 5.26e-04 | 112 | 110 | 5 | SM01381 | |
| Domain | GPCR_3_mtglu_rcpt | 9.40e-04 | 8 | 110 | 2 | IPR000162 | |
| Domain | MFS_dom | 1.18e-03 | 134 | 110 | 5 | IPR020846 | |
| Domain | Olfact_rcpt | 2.27e-03 | 393 | 110 | 8 | IPR000725 | |
| Domain | NCD3G | 2.57e-03 | 13 | 110 | 2 | PF07562 | |
| Domain | AA_permease_2 | 2.57e-03 | 13 | 110 | 2 | PF13520 | |
| Domain | GPCR_3_9-Cys_dom | 2.57e-03 | 13 | 110 | 2 | IPR011500 | |
| Domain | AA/rel_permease1 | 2.57e-03 | 13 | 110 | 2 | IPR002293 | |
| Domain | GPCR_3_CS | 2.99e-03 | 14 | 110 | 2 | IPR017979 | |
| Domain | MFS | 3.82e-03 | 108 | 110 | 4 | PS50850 | |
| Domain | TY | 4.41e-03 | 17 | 110 | 2 | SM00211 | |
| Domain | HEAT_type_2 | 4.41e-03 | 17 | 110 | 2 | IPR021133 | |
| Domain | - | 4.41e-03 | 17 | 110 | 2 | 4.10.800.10 | |
| Domain | THYROGLOBULIN_1_2 | 4.41e-03 | 17 | 110 | 2 | PS51162 | |
| Domain | Thyroglobulin_1 | 4.41e-03 | 17 | 110 | 2 | IPR000716 | |
| Domain | Thyroglobulin_1 | 4.41e-03 | 17 | 110 | 2 | PF00086 | |
| Domain | THYROGLOBULIN_1_1 | 4.41e-03 | 17 | 110 | 2 | PS00484 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 4.95e-03 | 18 | 110 | 2 | PS00754 | |
| Domain | SNF | 5.51e-03 | 19 | 110 | 2 | PF00209 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 5.51e-03 | 19 | 110 | 2 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 5.51e-03 | 19 | 110 | 2 | PS50267 | |
| Domain | Na/ntran_symport | 5.51e-03 | 19 | 110 | 2 | IPR000175 | |
| Domain | Glyco_trans_29 | 6.09e-03 | 20 | 110 | 2 | IPR001675 | |
| Domain | Glyco_transf_29 | 6.09e-03 | 20 | 110 | 2 | PF00777 | |
| Domain | TSP_1 | 6.11e-03 | 63 | 110 | 3 | PF00090 | |
| Domain | TSP1 | 6.66e-03 | 65 | 110 | 3 | SM00209 | |
| Domain | TSP1_rpt | 6.66e-03 | 65 | 110 | 3 | IPR000884 | |
| Domain | TSP1 | 6.66e-03 | 65 | 110 | 3 | PS50092 | |
| Domain | GPCR_3 | 6.71e-03 | 21 | 110 | 2 | IPR000337 | |
| Domain | K_chnl_dom | 6.71e-03 | 21 | 110 | 2 | IPR013099 | |
| Domain | Ion_trans_2 | 6.71e-03 | 21 | 110 | 2 | PF07885 | |
| Pathway | REACTOME_DOPAMINE_RECEPTORS | 1.88e-06 | 5 | 82 | 3 | M27301 | |
| Pathway | REACTOME_DOPAMINE_RECEPTORS | 1.88e-06 | 5 | 82 | 3 | MM15007 | |
| Pathway | WP_GPCRS_NONODORANT | 2.33e-05 | 266 | 82 | 9 | MM15843 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 5.11e-05 | 367 | 82 | 10 | M48346 | |
| Pubmed | A common variant in DRD3 receptor is associated with autism spectrum disorder. | 1.23e-08 | 128 | 116 | 8 | 19058789 | |
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 20164562 | ||
| Pubmed | Dopamine genes and pathological gambling in discordant sib-pairs. | 1.44e-07 | 4 | 116 | 3 | 17394052 | |
| Pubmed | Dopaminergic signaling in the cochlea: receptor expression patterns and deletion phenotypes. | 3.60e-07 | 5 | 116 | 3 | 22219295 | |
| Pubmed | Neuron-specific age-related decreases in dopamine receptor subtype mRNAs. | 3.60e-07 | 5 | 116 | 3 | 12509874 | |
| Pubmed | Association of serotonin and dopamine gene pathways with behavioral subphenotypes in dementia. | 3.60e-07 | 5 | 116 | 3 | 20685009 | |
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 18083900 | ||
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 9457173 | ||
| Pubmed | [Dopamine receptor signaling regulates human osteoclastogenesis]. | 3.60e-07 | 5 | 116 | 3 | 23445730 | |
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 26597879 | ||
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 19105202 | ||
| Pubmed | Dopamine receptor loss of function is not protective of rd1 rod photoreceptors in vivo. | 3.60e-07 | 5 | 116 | 3 | 20038975 | |
| Pubmed | Systematic analysis of dopamine receptor genes (DRD1-DRD5) in antipsychotic-induced weight gain. | 3.60e-07 | 5 | 116 | 3 | 20714340 | |
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 23753418 | ||
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 17509542 | ||
| Pubmed | Rod vision is controlled by dopamine-dependent sensitization of rod bipolar cells by GABA. | 7.18e-07 | 6 | 116 | 3 | 21982372 | |
| Pubmed | DISC1 regulates primary cilia that display specific dopamine receptors. | 7.18e-07 | 6 | 116 | 3 | 20531939 | |
| Pubmed | Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. | 7.18e-07 | 6 | 116 | 3 | 25594175 | |
| Pubmed | Retinal dopamine mediates multiple dimensions of light-adapted vision. | 7.18e-07 | 6 | 116 | 3 | 22764243 | |
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 2.94e-06 | 118 | 116 | 6 | 19156168 | |
| Pubmed | 2.99e-06 | 9 | 116 | 3 | 16525059 | ||
| Pubmed | Two-stage case-control association study of dopamine-related genes and migraine. | 2.99e-06 | 9 | 116 | 3 | 19772578 | |
| Pubmed | 4.26e-06 | 10 | 116 | 3 | 21083670 | ||
| Pubmed | Support for association between ADHD and two candidate genes: NET1 and DRD1. | 5.85e-06 | 11 | 116 | 3 | 15717291 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 32029712 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 37566200 | ||
| Pubmed | PV plasticity sustained through D1/5 dopamine signaling required for long-term memory consolidation. | 1.10e-05 | 2 | 116 | 2 | 26807952 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 14699430 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 33462188 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 22946653 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 19786093 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 26186971 | ||
| Pubmed | Differential roles of the dopamine 1-class receptors, D1R and D5R, in hippocampal dependent memory. | 1.10e-05 | 2 | 116 | 2 | 24843151 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 1831904 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 22203087 | ||
| Pubmed | DRD1 and DRD4 dopamine receptors in the etiology of preeclampsia. | 1.10e-05 | 2 | 116 | 2 | 26665568 | |
| Pubmed | Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity. | 1.10e-05 | 2 | 116 | 2 | 13679419 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 24135011 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 12393497 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 11823893 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 20180564 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 11500503 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 21893192 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 26763483 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 35188604 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 26112010 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 26174222 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 24552847 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 19279248 | ||
| Pubmed | The melanocortin agonist AP214 exerts anti-inflammatory and proresolving properties. | 1.10e-05 | 2 | 116 | 2 | 21703408 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 21906006 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 16774975 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 25429131 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 19204052 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 12626592 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 25154512 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 14997010 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 37337032 | ||
| Pubmed | Dopamine receptor mediation of the exploratory/hyperactivity effects of modafinil. | 1.10e-05 | 2 | 116 | 2 | 21412225 | |
| Pubmed | Melanocortin receptors form constitutive homo- and heterodimers. | 1.10e-05 | 2 | 116 | 2 | 15582585 | |
| Pubmed | 1.57e-05 | 45 | 116 | 4 | 25979088 | ||
| Pubmed | Identification of G protein-coupled receptor genes from the human genome sequence. | 1.72e-05 | 46 | 116 | 4 | 12044878 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 7609904 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 25299066 | ||
| Pubmed | Cation coupling properties of human concentrative nucleoside transporters hCNT1, hCNT2 and hCNT3. | 3.30e-05 | 3 | 116 | 2 | 17453413 | |
| Pubmed | A candidate syntenic genetic locus is associated with voluntary exercise levels in mice and humans. | 3.30e-05 | 3 | 116 | 2 | 24821406 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 21115476 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 25339698 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 8463333 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 7680645 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 17696452 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 23195617 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 19695183 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 18563476 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 28339036 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 18081165 | ||
| Pubmed | Characterization of deoxyribonucleoside transport mediated by concentrative nucleoside transporters. | 3.30e-05 | 3 | 116 | 2 | 33910126 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 24891617 | ||
| Pubmed | ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid Malignancies. | 3.30e-05 | 3 | 116 | 2 | 26788497 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 19171671 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 19747903 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 19889022 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 22710646 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 8954958 | ||
| Pubmed | Cognitive functioning in affected sibling pairs with ADHD: familial clustering and dopamine genes. | 3.30e-05 | 3 | 116 | 2 | 18665883 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 9129202 | ||
| Pubmed | Differential D1 and D5 receptor regulation and degradation of the angiotensin type 1 receptor. | 3.30e-05 | 3 | 116 | 2 | 18172057 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 32183536 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 28385889 | ||
| Pubmed | Dopamine receptor genes and migraine with and without aura: an association study. | 3.30e-05 | 3 | 116 | 2 | 12047334 | |
| Pubmed | A novel metabotropic glutamate receptor expressed in the retina and olfactory bulb. | 3.30e-05 | 3 | 116 | 2 | 7722646 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 12867509 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 17679637 | ||
| Pubmed | 3.77e-05 | 56 | 116 | 4 | 23934736 | ||
| Pubmed | 4.34e-05 | 58 | 116 | 4 | 11140838 | ||
| Pubmed | 4.60e-05 | 21 | 116 | 3 | 18270970 | ||
| Pubmed | Novel binding motif of ACTH analogues at the melanocortin receptors. | 6.59e-05 | 4 | 116 | 2 | 19743876 | |
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 16962565 | ||
| Pubmed | Paracrine effects of bFGF and KGF on the process of mouse blastocyst implantation. | 6.59e-05 | 4 | 116 | 2 | 9547510 | |
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 19235789 | ||
| GeneFamily | Solute carriers | SLC52A1 SLC7A13 SLC22A23 SLC43A1 SLC28A3 SLC25A25 SLC6A1 SLC6A6 SLCO5A1 SLC7A4 SLC12A4 SLC16A14 UCP3 SLC28A2 SLC35F2 SLC16A7 | 1.38e-10 | 395 | 92 | 16 | 752 |
| GeneFamily | Dopamine receptors | 1.27e-06 | 5 | 92 | 3 | 181 | |
| GeneFamily | Maestro heat like repeat containing | 2.04e-05 | 11 | 92 | 3 | 636 | |
| GeneFamily | Melanocortin receptors | 2.54e-04 | 5 | 92 | 2 | 236 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 7.03e-04 | 8 | 92 | 2 | 281 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 3.02e-08 | 188 | 114 | 8 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.01e-08 | 195 | 114 | 8 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.04e-07 | 185 | 114 | 7 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.03e-07 | 190 | 114 | 7 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.69e-07 | 193 | 114 | 7 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 6.93e-07 | 194 | 114 | 7 | 8dcde77767b23e75360adb316cdccf56a00e3726 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.50e-07 | 200 | 114 | 7 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rxfp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.12e-06 | 131 | 114 | 6 | 81efe8b0ca4377e557a42ddb12aecaf3f46b15bf | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.79e-06 | 174 | 114 | 6 | 33e5903adb746f693433bdca11a75c508bbf50c0 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-interstitial_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.79e-06 | 174 | 114 | 6 | ca0c2f42544092848541863c4a47b334e6828b8a | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.18e-06 | 176 | 114 | 6 | 057d2759fdc67176c25802b57a78064d8cc93205 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.18e-06 | 176 | 114 | 6 | b81e5d23b31cefc8d374ef403e21acc390c14a80 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.39e-06 | 177 | 114 | 6 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.49e-06 | 182 | 114 | 6 | 2cc434e46985c66fc36de05344a67aa96d90abc9 | |
| ToppCell | facs-Lung-24m-Endothelial-lymphatic_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.49e-06 | 182 | 114 | 6 | 0cde2775bdaaa2172499925bd59b0ac2d545eb27 | |
| ToppCell | facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.49e-06 | 182 | 114 | 6 | 3e7457b2a70b45735fb75d6617b7f34cef28758e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.97e-06 | 184 | 114 | 6 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.22e-06 | 185 | 114 | 6 | 4c42bd3cd72f91f4d4ebb849069a03761a2cd662 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.48e-06 | 186 | 114 | 6 | f73cb91e74a806858650ae97f543fc779ba4cff8 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.48e-06 | 186 | 114 | 6 | 8694ca16c9780729f4fba67ba20e35745f1eb4e9 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.74e-06 | 187 | 114 | 6 | dffa8447c2f3fdacf39a7258c6b4e81a25245041 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.29e-06 | 189 | 114 | 6 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.57e-06 | 190 | 114 | 6 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.57e-06 | 190 | 114 | 6 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.86e-06 | 191 | 114 | 6 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 1.02e-05 | 192 | 114 | 6 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 1.02e-05 | 192 | 114 | 6 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.05e-05 | 193 | 114 | 6 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.08e-05 | 194 | 114 | 6 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | 18-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 1.11e-05 | 195 | 114 | 6 | f86737bff21d81673238813df61a15cfe88d0b15 | |
| ToppCell | IPF-Stromal-Fibroblast|IPF / Disease state, Lineage and Cell class | 1.14e-05 | 196 | 114 | 6 | f7ae604ba32b322d86d68b2b54892e7c6ab06c49 | |
| ToppCell | 15-Airway-Mesenchymal-Mesenchyme_SERPINF1-high|Airway / Age, Tissue, Lineage and Cell class | 1.21e-05 | 198 | 114 | 6 | 3d76393e72eed59b4dd16130ef5dd1d331ba5711 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-TSPAN12-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.28e-05 | 200 | 114 | 6 | 523d799eb315b33b77e02d5b7db63dad8450c4e1 | |
| ToppCell | 15-Airway|15 / Age, Tissue, Lineage and Cell class | 1.28e-05 | 200 | 114 | 6 | ba4b8d5becf81351901c2ecac74ffa28e29586f3 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-TSPAN12|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.28e-05 | 200 | 114 | 6 | e5cef95e563a6e793ade190ce88c999bfa0af460 | |
| ToppCell | Neuronal-Inhibitory-iA|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.28e-05 | 200 | 114 | 6 | 5ef4a3dc18a44292184a59ced916183c0699b01e | |
| ToppCell | IIH-CD4-CD8_2|IIH / Condition, Cell_class and T cell subcluster | 2.74e-05 | 137 | 114 | 5 | 5614a086f5f698e0965f3c7699cffefec5c3b87e | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_interstitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.59e-05 | 145 | 114 | 5 | 778655fffd73df101e656154a41b478a1b695116 | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.59e-05 | 145 | 114 | 5 | afed661aef990edb8e7012ab67ace56443520c9f | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.57e-05 | 159 | 114 | 5 | 2f6c60ddff2208a68146f9786143d9aefd528840 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.57e-05 | 159 | 114 | 5 | e47d9fefa9e9fcc7812336874a456077ec44b722 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.57e-05 | 159 | 114 | 5 | ded4e3626a62fb6334403b7213b467fb7e8131c3 | |
| ToppCell | NS-critical-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.74e-05 | 160 | 114 | 5 | c61869d9dbba250270e59366e15af204e5b4395d | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.09e-05 | 162 | 114 | 5 | ec29c6f1c31e41ddcb041a49c593910edaf0532c | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Myeloid-macrophage|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-05 | 162 | 114 | 5 | 59147406c28b7cdf43a1815f99c15c2bd6ae8fa3 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Myeloid|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-05 | 162 | 114 | 5 | 8e0bcc23c3086fc4b0c9dbeec13a7edaf6b83750 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Myeloid-macrophage|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-05 | 162 | 114 | 5 | 736fdcbd0f7d50fc297f13d36ab4c0dc82ad509c | |
| ToppCell | E12.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.27e-05 | 163 | 114 | 5 | c21114826bee1b05b411984326fef6b6e0d05316 | |
| ToppCell | E12.5-Endothelial-lymphatic_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.27e-05 | 163 | 114 | 5 | 5d49414432db259a19df50d7944581d00b69f537 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.45e-05 | 164 | 114 | 5 | 4cfc9f92e49f86d3639e018b35b6a60dc62f494a | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.45e-05 | 164 | 114 | 5 | 7a8e5ef52a8fd2877d59ef0696af8a7af90bbed6 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.45e-05 | 164 | 114 | 5 | 5e5bd81414ea2d64f73cdef19a0a78c17bec8c18 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.45e-05 | 164 | 114 | 5 | f13b8d9b7f42193f333d9a77571a1dde6bbb48d8 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Myeloid|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-05 | 165 | 114 | 5 | 518ee34c18065100a2f2c6e407d3a7866b908593 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Myeloid-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-05 | 165 | 114 | 5 | becb8f726b84509ec29c75b530a3fe757651301d | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Myeloid-macrophage|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-05 | 165 | 114 | 5 | ae8dd9c00f96590f27ed21cd6314f4577e00e312 | |
| ToppCell | Thalamus-Hematopoietic|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.83e-05 | 166 | 114 | 5 | 76d60ac7ac5d1eaf530f0c741d9c48e0bd58396b | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.23e-05 | 168 | 114 | 5 | aaafa7243c44e6852d92e3445335fc4a1018f416 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-interstitial_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.23e-05 | 168 | 114 | 5 | 06787d4f08ddf052127404a0ea6a85e1b048e206 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.23e-05 | 168 | 114 | 5 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_SLITRK6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.43e-05 | 169 | 114 | 5 | 1c9e54e7b14eb99996590fb93b257cf881a9f184 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 7.64e-05 | 170 | 114 | 5 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 171 | 114 | 5 | 7ca404539344e14dcd90c746c9122f713a7db78b | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 171 | 114 | 5 | ab113c8e773b0af47a87aed50e96be3ba71c3c82 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-05 | 173 | 114 | 5 | 31ea04e65876c42b90245d280f0b6439bfffbace | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-05 | 173 | 114 | 5 | 1cff815536f620e32b9805666e1aa711462c2d25 | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|(0)_Normal/No_Treatment / Stress and Cell class | 8.30e-05 | 173 | 114 | 5 | c2a0f674681836b5a868c13f67caa7d555ef6519 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.53e-05 | 174 | 114 | 5 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.53e-05 | 174 | 114 | 5 | 6b5ff1cc5fe6705f7ea70b5a892dfbf91e32288d | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-05 | 175 | 114 | 5 | f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_GRIP2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.76e-05 | 175 | 114 | 5 | 0c648e7f67ffbe3b476a2ca77d246554f8cd1882 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-05 | 177 | 114 | 5 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.24e-05 | 177 | 114 | 5 | 57033ee0d49a4a50fc25328a4a44d4de2b35f505 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-05 | 177 | 114 | 5 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 9.49e-05 | 178 | 114 | 5 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.49e-05 | 178 | 114 | 5 | 30d2b54462fd16222ad2e3806be6143e834b29e0 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 9.75e-05 | 179 | 114 | 5 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.75e-05 | 179 | 114 | 5 | e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.00e-04 | 180 | 114 | 5 | 66c7b02d85e32ba3e7530d0c4aff17e7525ccdd8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 182 | 114 | 5 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 182 | 114 | 5 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NK|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.05e-04 | 182 | 114 | 5 | fb503f8ecd013f1f2161a5841572b57cfcddb6fa | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-04 | 183 | 114 | 5 | d67454baf0cf791a743b51afd1cb25bfb5765385 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-cDC1|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-04 | 183 | 114 | 5 | 661bfc8f5f683b0f4c12bdd359e67c513b181678 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-6_RORB_HPCA|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-04 | 183 | 114 | 5 | c7e94fe3e7669db9304b249979fef7a69c30a143 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-04 | 183 | 114 | 5 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-04 | 183 | 114 | 5 | e49ac8314b6fe98426b1514ea68d646297b8bc0f | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 1.14e-04 | 185 | 114 | 5 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-04 | 186 | 114 | 5 | e41f14aee8cfbf76b8d0d4695a6170e2cd92aec8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-04 | 186 | 114 | 5 | fef543f188edb0d1704d9c6ace366a0f8017bf53 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-04 | 186 | 114 | 5 | b3633cd4e360c5b45060c50b4f606d483e03a89a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Micro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-04 | 186 | 114 | 5 | 9dd31dc9af1704f35c74de726a6c27fa21e9a014 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 187 | 114 | 5 | 23a42c172d5cc36cb8793c0bc2ce357c6c8e5d39 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.20e-04 | 187 | 114 | 5 | 59d28f4ee1d463ae20abb8d7e7399b504d80698a | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 187 | 114 | 5 | 5ce7cf02990465b6f793205e4be07e8337b3570a | |
| ToppCell | Control-Myeloid-MoAM5|Control / Disease group,lineage and cell class （2021.01.30） | 1.20e-04 | 187 | 114 | 5 | 8769341be67382cea2a590d962f4def7c39de883 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.20e-04 | 187 | 114 | 5 | 25adf648c05c21534b4913254e73d43fc5f64e06 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.20e-04 | 187 | 114 | 5 | 3b0cfa9e5ea5e7d6dda689c328b9b5110b43ee1d | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.20e-04 | 187 | 114 | 5 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 187 | 114 | 5 | 17a37fc3a1d62fef3137e5ff26a84c0b8c80e124 | |
| Drug | U-99363E | 1.22e-07 | 3 | 114 | 3 | CID000133107 | |
| Drug | U 101958 | 4.87e-07 | 4 | 114 | 3 | CID005311492 | |
| Drug | MK-458 | 4.87e-07 | 4 | 114 | 3 | CID000057532 | |
| Drug | DK-118 | 4.87e-07 | 4 | 114 | 3 | CID000145953 | |
| Drug | azaperone | 5.74e-07 | 14 | 114 | 4 | CID000015443 | |
| Drug | SKF 75670 | 7.80e-07 | 15 | 114 | 4 | CID000173870 | |
| Drug | AC1L2AAS | 7.80e-07 | 15 | 114 | 4 | CID000068714 | |
| Drug | tilozepine | 1.21e-06 | 5 | 114 | 3 | CID000172286 | |
| Drug | C9H11N3O2 | 1.21e-06 | 5 | 114 | 3 | CID000123703 | |
| Drug | SKF 77434 | 1.21e-06 | 5 | 114 | 3 | CID000001241 | |
| Drug | Levodopa | 1.21e-06 | 5 | 114 | 3 | DB01235 | |
| Drug | dazopride | 1.21e-06 | 5 | 114 | 3 | CID000054801 | |
| Drug | azapride | 1.21e-06 | 5 | 114 | 3 | CID003036441 | |
| Drug | 2-di-n-propylaminoindan | 1.21e-06 | 5 | 114 | 3 | CID000130402 | |
| Drug | mezilamine | 1.21e-06 | 5 | 114 | 3 | CID000068678 | |
| Drug | proterguride | 1.21e-06 | 5 | 114 | 3 | CID000071999 | |
| Drug | NO 756 | 1.21e-06 | 5 | 114 | 3 | CID000129967 | |
| Drug | SKF85174 | 1.21e-06 | 5 | 114 | 3 | CID000132435 | |
| Drug | l-CSL | 1.21e-06 | 5 | 114 | 3 | CID006918538 | |
| Drug | 3-iodobenzamide | 1.21e-06 | 5 | 114 | 3 | CID000202425 | |
| Drug | piquindone | 1.21e-06 | 5 | 114 | 3 | CID000121903 | |
| Drug | AMPT | 1.73e-06 | 18 | 114 | 4 | CID000002112 | |
| Drug | DAR-0100A | 1.87e-06 | 41 | 114 | 5 | CID000060759 | |
| Drug | Ro 41-9067 | 2.18e-06 | 19 | 114 | 4 | CID000125800 | |
| Drug | tiospirone | 2.18e-06 | 19 | 114 | 4 | CID000055751 | |
| Drug | A66359 | 2.42e-06 | 6 | 114 | 3 | CID000173657 | |
| Drug | CI-943 | 2.42e-06 | 6 | 114 | 3 | CID000146009 | |
| Drug | propylbutyldopamine | 2.42e-06 | 6 | 114 | 3 | CID000156067 | |
| Drug | LON-954 | 2.42e-06 | 6 | 114 | 3 | CID006441097 | |
| Drug | 7-hydroxyamoxapine | 2.42e-06 | 6 | 114 | 3 | CID000162242 | |
| Drug | BAM-1110 | 2.42e-06 | 6 | 114 | 3 | CID003064755 | |
| Drug | AC1MI81B | 2.42e-06 | 6 | 114 | 3 | CID003039938 | |
| Drug | HW-165 | 2.42e-06 | 6 | 114 | 3 | CID000125677 | |
| Drug | 2'-ISP | 2.42e-06 | 6 | 114 | 3 | CID000128389 | |
| Drug | Rotigotine | 2.42e-06 | 6 | 114 | 3 | DB05271 | |
| Drug | pergolide sulfone | 2.42e-06 | 6 | 114 | 3 | CID000155750 | |
| Drug | pergolide sulfoxide | 2.42e-06 | 6 | 114 | 3 | CID000155749 | |
| Drug | AC1L1JFX | 2.42e-06 | 6 | 114 | 3 | CID000005023 | |
| Drug | N,N-dimethyldopamine | 2.42e-06 | 6 | 114 | 3 | CID000152427 | |
| Drug | oxiperomide | 2.42e-06 | 6 | 114 | 3 | CID000068634 | |
| Drug | AC1L1I8U | 2.42e-06 | 6 | 114 | 3 | CID000055036 | |
| Drug | p-bromospiperone | 2.42e-06 | 6 | 114 | 3 | CID000156386 | |
| Drug | MDO-NPA | 2.42e-06 | 6 | 114 | 3 | CID000133642 | |
| Drug | LY293284 | 2.42e-06 | 6 | 114 | 3 | CID000132345 | |
| Drug | 5,6-ADTN | 2.42e-06 | 6 | 114 | 3 | CID000037630 | |
| Drug | GBR 13098 | 2.42e-06 | 6 | 114 | 3 | CID000132672 | |
| Drug | flupenthixol decanoate | 2.42e-06 | 6 | 114 | 3 | CID006434100 | |
| Drug | abeorphine | 2.42e-06 | 6 | 114 | 3 | CID000133849 | |
| Drug | buspirone | 3.07e-06 | 80 | 114 | 6 | CID000002477 | |
| Drug | AC1L9NGT | 4.22e-06 | 7 | 114 | 3 | CID000449733 | |
| Drug | N,N-dipropyl-5,6-ADTN | 4.22e-06 | 7 | 114 | 3 | CID000122167 | |
| Drug | UH 242 | 4.22e-06 | 7 | 114 | 3 | CID000125884 | |
| Drug | NCQ 298 | 4.22e-06 | 7 | 114 | 3 | CID000086228 | |
| Drug | Dopamine | 4.22e-06 | 7 | 114 | 3 | DB00988 | |
| Drug | LE300 | 4.22e-06 | 7 | 114 | 3 | CID004350931 | |
| Drug | FLB 457 | 4.22e-06 | 7 | 114 | 3 | CID000129497 | |
| Drug | isofloxythepin | 4.22e-06 | 7 | 114 | 3 | CID000115193 | |
| Drug | FIDA2 | 4.22e-06 | 7 | 114 | 3 | CID000130295 | |
| Drug | alpiropride | 4.22e-06 | 7 | 114 | 3 | CID000071253 | |
| Drug | 7-methyl-6,7,8,9,14,15-hexahydro-5H-benz(d)indolo(2,3-g)azecine | 4.22e-06 | 7 | 114 | 3 | ctd:C409874 | |
| Drug | baclofen | 5.46e-06 | 191 | 114 | 8 | CID000002284 | |
| Drug | 5,6-dihydroxy-2-dimethylaminotetralin | 5.86e-06 | 24 | 114 | 4 | CID000037032 | |
| Drug | TL-99 | 5.86e-06 | 24 | 114 | 4 | CID000122132 | |
| Drug | DP-8OH-3CA | 6.72e-06 | 8 | 114 | 3 | CID000086131 | |
| Drug | 2,3,4,5-Tetrahydro-1H-benzo[d]azepine | 6.72e-06 | 8 | 114 | 3 | CID001400242 | |
| Drug | 1-methyl-3,4-dihydroisoquinoline | 6.72e-06 | 8 | 114 | 3 | CID000231502 | |
| Drug | 5-methoxy-1-methyl-2-(n-propylamino)tetralin | 6.72e-06 | 8 | 114 | 3 | CID000122334 | |
| Drug | AC1L1F9K | 6.72e-06 | 8 | 114 | 3 | CID000003142 | |
| Drug | UH232 | 6.72e-06 | 8 | 114 | 3 | CID005311190 | |
| Drug | L-745,870 | 6.72e-06 | 8 | 114 | 3 | CID005311200 | |
| Drug | SCH-12679 | 6.72e-06 | 8 | 114 | 3 | CID000005024 | |
| Drug | LEK-8829 | 6.72e-06 | 8 | 114 | 3 | CID000164460 | |
| Drug | alizapride | 6.72e-06 | 8 | 114 | 3 | CID000043008 | |
| Drug | NNC 756 | 6.72e-06 | 8 | 114 | 3 | CID000132420 | |
| Drug | Sch 23982 | 6.72e-06 | 8 | 114 | 3 | CID000119353 | |
| Drug | BW 737C | 6.72e-06 | 8 | 114 | 3 | CID000132241 | |
| Drug | hydergine | 6.72e-06 | 8 | 114 | 3 | CID000168870 | |
| Drug | N-n-propylnorapomorphine | 6.95e-06 | 25 | 114 | 4 | CID000030137 | |
| Drug | AC1Q5UBL | 8.96e-06 | 146 | 114 | 7 | CID000005466 | |
| Drug | RU 24926 | 9.57e-06 | 27 | 114 | 4 | CID000122203 | |
| Drug | 3',4'-dihydroxynomifensine | 1.00e-05 | 9 | 114 | 3 | CID000194310 | |
| Drug | BTCP | 1.00e-05 | 9 | 114 | 3 | CID000123692 | |
| Drug | CQ 32-084 | 1.00e-05 | 9 | 114 | 3 | CID000068847 | |
| Drug | 11-OH-NPa | 1.00e-05 | 9 | 114 | 3 | CID000127708 | |
| Drug | NIASP | 1.00e-05 | 9 | 114 | 3 | CID006439184 | |
| Drug | halopemide | 1.00e-05 | 9 | 114 | 3 | CID000065490 | |
| Drug | PAOPA | 1.00e-05 | 9 | 114 | 3 | CID000129409 | |
| Drug | [11c]tmsx | 1.00e-05 | 9 | 114 | 3 | CID005461878 | |
| Drug | AC1OCEMN | 1.00e-05 | 9 | 114 | 3 | CID006917765 | |
| Drug | U91356A | 1.00e-05 | 9 | 114 | 3 | CID000132955 | |
| Drug | Rds-127 | 1.43e-05 | 10 | 114 | 3 | CID000134064 | |
| Drug | 5-OH-DPAT | 1.43e-05 | 10 | 114 | 3 | CID000172267 | |
| Drug | clebopride | 1.43e-05 | 10 | 114 | 3 | CID000002780 | |
| Drug | cyclo(Leu-Gly) | 1.43e-05 | 10 | 114 | 3 | CID000002902 | |
| Drug | CM 29-712 | 1.43e-05 | 10 | 114 | 3 | CID000159842 | |
| Drug | 2-(di-n-propylamino)tetralin | 1.43e-05 | 10 | 114 | 3 | CID000090285 | |
| Drug | 1-methyl-1,2,3,4-tetrahydroisoquinoline | 1.43e-05 | 10 | 114 | 3 | CID000092214 | |
| Drug | DO 710 | 1.43e-05 | 10 | 114 | 3 | CID003084985 | |
| Drug | U-86170F | 1.43e-05 | 10 | 114 | 3 | CID000131559 | |
| Drug | SDZ 208-912 | 1.43e-05 | 10 | 114 | 3 | CID000058145 | |
| Disease | Attention Deficit Disorder | 1.32e-06 | 22 | 111 | 4 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 1.32e-06 | 22 | 111 | 4 | C1321905 | |
| Disease | Attention deficit hyperactivity disorder | 1.90e-06 | 24 | 111 | 4 | C1263846 | |
| Disease | Alcoholic Intoxication, Chronic | 8.22e-06 | 268 | 111 | 8 | C0001973 | |
| Disease | pervasive developmental disorder (is_marker_for) | 1.40e-05 | 2 | 111 | 2 | DOID:0060040 (is_marker_for) | |
| Disease | Hereditary attention deficit-hyperactivity disorder | 1.40e-05 | 2 | 111 | 2 | cv:CN324066 | |
| Disease | ATTENTION DEFICIT-HYPERACTIVITY DISORDER | 1.40e-05 | 2 | 111 | 2 | 143465 | |
| Disease | Attention deficit hyperactivity disorder | 1.40e-05 | 2 | 111 | 2 | cv:C1263846 | |
| Disease | Depressive disorder | 1.42e-05 | 289 | 111 | 8 | C0011581 | |
| Disease | attention deficit hyperactivity disorder (is_implicated_in) | 5.64e-05 | 20 | 111 | 3 | DOID:1094 (is_implicated_in) | |
| Disease | withdrawal disorder (biomarker_via_orthology) | 1.39e-04 | 5 | 111 | 2 | DOID:0060001 (biomarker_via_orthology) | |
| Disease | CCL3 measurement | 1.39e-04 | 5 | 111 | 2 | EFO_0010770 | |
| Disease | Menkes disease (implicated_via_orthology) | 1.39e-04 | 5 | 111 | 2 | DOID:1838 (implicated_via_orthology) | |
| Disease | CCL23 measurement | 2.91e-04 | 7 | 111 | 2 | EFO_0009417 | |
| Disease | C-C motif chemokine 23 measurement | 2.91e-04 | 7 | 111 | 2 | EFO_0008049 | |
| Disease | C-C motif chemokine 3-like 1 measurement | 3.87e-04 | 8 | 111 | 2 | EFO_0008052 | |
| Disease | Mental Depression | 4.09e-04 | 254 | 111 | 6 | C0011570 | |
| Disease | Unipolar Depression | 4.53e-04 | 259 | 111 | 6 | C0041696 | |
| Disease | C-C motif chemokine 18 measurement | 4.96e-04 | 9 | 111 | 2 | EFO_0008046 | |
| Disease | Melancholia | 4.98e-04 | 41 | 111 | 3 | C0025193 | |
| Disease | Depression, Neurotic | 4.98e-04 | 41 | 111 | 3 | C0282126 | |
| Disease | Cleft palate, isolated | 5.34e-04 | 42 | 111 | 3 | C1837218 | |
| Disease | Depressive Syndrome | 5.34e-04 | 42 | 111 | 3 | C0086133 | |
| Disease | Endogenous depression | 6.99e-04 | 46 | 111 | 3 | C0011573 | |
| Disease | C-C motif chemokine 15 measurement | 7.54e-04 | 11 | 111 | 2 | EFO_0008043 | |
| Disease | C-C motif chemokine 16 measurement | 9.03e-04 | 12 | 111 | 2 | EFO_0008044 | |
| Disease | Ck-beta-8-1 measurement | 9.03e-04 | 12 | 111 | 2 | EFO_0008085 | |
| Disease | ovarian carcinoma | 1.38e-03 | 321 | 111 | 6 | EFO_0001075 | |
| Disease | urate measurement | BNC2 SLC52A1 FOLR2 DHX38 STAB1 PPP2R1B THBS1 FGFR1 MARVELD3 UBE2W | 2.05e-03 | 895 | 111 | 10 | EFO_0004531 |
| Disease | C-C motif chemokine 3 measurement | 2.06e-03 | 18 | 111 | 2 | EFO_0008051 | |
| Disease | Phenyllactate (PLA) measurement | 2.30e-03 | 19 | 111 | 2 | EFO_0021662 | |
| Disease | Cannabis use, age at onset | 2.30e-03 | 19 | 111 | 2 | EFO_0004847, EFO_0007585 | |
| Disease | serum zinc measurement | 2.30e-03 | 19 | 111 | 2 | EFO_0005268 | |
| Disease | freckles | 2.55e-03 | 20 | 111 | 2 | EFO_0003963 | |
| Disease | Osteogenesis imperfecta | 2.81e-03 | 21 | 111 | 2 | cv:C0029434 | |
| Disease | Amphetamine-Related Disorders | 2.87e-03 | 75 | 111 | 3 | C0236733 | |
| Disease | Amphetamine Abuse | 2.87e-03 | 75 | 111 | 3 | C0236807 | |
| Disease | Amphetamine Addiction | 2.87e-03 | 75 | 111 | 3 | C0236804 | |
| Disease | non-small cell lung carcinoma | 2.87e-03 | 75 | 111 | 3 | EFO_0003060 | |
| Disease | Alzheimer's disease (is_marker_for) | 2.92e-03 | 257 | 111 | 5 | DOID:10652 (is_marker_for) | |
| Disease | depressive disorder (implicated_via_orthology) | 3.08e-03 | 22 | 111 | 2 | DOID:1596 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 3.12e-03 | 261 | 111 | 5 | C0004352 | |
| Disease | Manic | 3.21e-03 | 78 | 111 | 3 | C0338831 | |
| Disease | nicotine dependence | 3.21e-03 | 78 | 111 | 3 | EFO_0003768 | |
| Disease | epilepsy (implicated_via_orthology) | 3.40e-03 | 163 | 111 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Cleft Palate | 3.57e-03 | 81 | 111 | 3 | C0008925 | |
| Disease | airway responsiveness measurement | 3.67e-03 | 24 | 111 | 2 | EFO_0006897 | |
| Disease | Epilepsy, Cryptogenic | 3.70e-03 | 82 | 111 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 3.70e-03 | 82 | 111 | 3 | C0751111 | |
| Disease | Aura | 3.70e-03 | 82 | 111 | 3 | C0236018 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLSMAVTKLGCSCSS | 921 | Q14146 | |
| MTTLFCINALSEACG | 511 | P30154 | |
| CLQILSCASKSMSEG | 1051 | Q8IZF5 | |
| AALSCLMLVTALGSQ | 6 | P55773 | |
| LMASLLACGICQASG | 16 | A8MTB9 | |
| QTGTCLMVAALCFVL | 371 | Q96BA8 | |
| CTALMLAICEGSSEI | 206 | Q9BXX2 | |
| CTIEGCNMVFSSLRS | 471 | Q6ZN30 | |
| GTCSTTLIAIAGMTC | 356 | P35670 | |
| GMTCASCVSNIERNL | 496 | P35670 | |
| LSSSSIDCLCAMINL | 466 | Q9H9E3 | |
| LCLNQETVCLASTAM | 86 | Q9Y297 | |
| CTCSGMSGLITLSRN | 131 | Q9BZ11 | |
| LVCTMALCSCAQVGT | 11 | P55774 | |
| VAAGSICAMNTVLLS | 321 | O43246 | |
| AFDIMCSTASILNLC | 101 | P21728 | |
| ILSMVLCCGIRNSSV | 221 | P60033 | |
| AASGLCELLSVNSCM | 841 | Q68CQ1 | |
| IMCSTASILNLCVIS | 121 | P21918 | |
| DVITCSSMLSSLCFL | 121 | Q01726 | |
| SMATLLARAGVSCCE | 266 | Q96P11 | |
| INICQMTECISLASG | 116 | Q9Y442 | |
| AVCVMLNLAGSILSC | 101 | O60320 | |
| LMTNIVCGQLVASAC | 151 | Q8NGY0 | |
| DTCAQCLSRILSLMG | 536 | Q14667 | |
| LCMSLSGLNQVGCAA | 546 | Q96II8 | |
| GISLQAMSCSEELQC | 301 | O76014 | |
| AMLALNCICPATSTL | 496 | Q5JUK3 | |
| SSVFGAMQLLCLLTC | 356 | O75387 | |
| TESLDMCISGLCQIV | 146 | Q8N6G6 | |
| CMLAGADIVLSTCTI | 66 | Q8NGK2 | |
| CIICFTCVGSQLSMS | 21 | B0L3A2 | |
| CGVSALSMLTCSSVL | 166 | Q6UX65 | |
| TLCLLMNGLTSSFCS | 151 | Q8TDS7 | |
| CCLGMVLASFSSSVV | 96 | O60669 | |
| LCTASILISCCASAM | 201 | Q9HB14 | |
| IFLGNLVLMDSCCSS | 61 | A6NET4 | |
| CLMAQLTFCAGSEIS | 161 | O60431 | |
| TISLSGCAVQMFLSL | 91 | Q8NGS8 | |
| TISFAVCAIQMCLSL | 91 | Q8NGT2 | |
| VCAIQMCLSLSTGST | 96 | Q8NGT2 | |
| MCLSLSTGSTECLLL | 101 | Q8NGT2 | |
| TTTMTTNVCACLAIG | 131 | Q96R08 | |
| VCMVSRAICSSTQAG | 796 | Q8NDA8 | |
| CSLGYSILLMVTCTV | 751 | O00222 | |
| LTALMGCCVSDLISR | 101 | Q9Y693 | |
| VMLCTASIFNLCAIS | 116 | P21917 | |
| ANLSLSDTLVCVMCI | 76 | Q99463 | |
| TLRTSCLLGCAVMQD | 1021 | Q86XA9 | |
| TLTIRVCACDSQGNM | 581 | Q9Y6N8 | |
| CTGAFLISCMVGSVI | 381 | P11362 | |
| VSTCVILSGMTNIIC | 11 | Q6P9A2 | |
| LLVCVATMCSAQDRT | 11 | P14207 | |
| TCLSQVGSFSMCIEV | 216 | O60503 | |
| TVAMACSGALTALCC | 271 | Q96A59 | |
| LCRICQMAAASSSNL | 551 | Q9H992 | |
| DSMICISLVASICNL | 121 | P41968 | |
| SSLACIISVVGMRCT | 91 | P57739 | |
| ASLGVALTTSMCCNK | 261 | Q9Y3R0 | |
| CFAVSLSVTVALGCM | 816 | Q13255 | |
| IICLVGTISLACNDM | 21 | P21781 | |
| TTTMTTRVCACLAIG | 131 | Q8NGF7 | |
| MSTCRLILCCNSTSK | 156 | P40938 | |
| ALLMALVVLSCKSSC | 6 | P05013 | |
| SCTQVAGCLVSLSML | 276 | Q9NUT2 | |
| LSCRISSTAVCFMSG | 1361 | A6NES4 | |
| LVTQRSLGDLIMSCC | 266 | Q96P20 | |
| CVFVTPSLLSAMCSL | 1606 | Q86VV8 | |
| LNATMCATTRTICAI | 426 | P49591 | |
| CSICLSLMTNPVSIN | 16 | O00635 | |
| CMLLGCLNSGTSFVS | 326 | P31641 | |
| IIVCCINSCTSMFAG | 321 | P30531 | |
| TSIICGCSCLGVMAL | 36 | A0A087WTH1 | |
| DTAMTQIIGNCVCLL | 386 | Q6UX01 | |
| AMLIQGAVSLNLCVC | 191 | Q7RTX9 | |
| GMAVDCSTLTSKCLL | 61 | P09758 | |
| TTASIALVSCLAMCV | 471 | A1A5C7 | |
| SCQLCGTKVSTRASM | 1226 | P57071 | |
| LAMICSGVSLLCFST | 506 | Q9H2Y9 | |
| CTVYCLGTILSMQIS | 241 | P46977 | |
| CAVVMSAGAILNSSL | 296 | Q96JF0 | |
| VCLALTTMCTSLLLV | 11 | Q9BVH7 | |
| ACFMTACIAGILSST | 601 | Q9HAS3 | |
| GQMLSLCICGTAITS | 46 | Q8IXU6 | |
| CCCTLLTAISMSAIA | 161 | Q9UP95 | |
| GACVSLISACMAGIL | 571 | O43868 | |
| LQANVVVMCSSACLA | 981 | Q9Y2K9 | |
| VASGICDNLLTCVMR | 111 | Q96CD2 | |
| ETLATMLACLQACAG | 646 | A5YKK6 | |
| GVFVLLACGTMSSTC | 376 | Q6KCM7 | |
| LAGCTTGAMAVTCAQ | 121 | P55916 | |
| TSPSLCLVCEMSSLF | 401 | Q70EK9 | |
| AMAVGALSSSLLVTC | 6 | Q2TAL6 | |
| ALSSSLLVTCCLMVA | 11 | Q2TAL6 | |
| LQAICGISCDELSSM | 266 | P07996 | |
| SMSSEVCQLCLEALT | 1016 | Q9C0E2 | |
| TLALVLAMACCTSNV | 116 | Q9NWF4 | |
| TPLSATLSLVMSQCC | 51 | Q96G75 | |
| SLTGFRCVVCMQTVT | 1016 | Q96K83 | |
| ALVMLSFGACCSTQT | 76 | P05543 | |
| SCTLMALQSILSIAG | 481 | Q6ZS81 | |
| GAMSVVSACVLLTQC | 291 | Q9H1K6 | |
| ANCSQVGTMVTCTCL | 2106 | Q9NY15 | |
| VSCDMGCSSEILLIV | 961 | Q92620 | |
| CAILAMTSTLCSAEI | 56 | Q8TCU3 | |
| LTQGCMLCLGQSTFL | 116 | Q86UU1 | |
| LQCGMEVNSSILSGC | 81 | Q96AP4 | |
| VTLCLVEPMGCTSTL | 1171 | Q7Z7G8 | |
| KVSSSSALCQCIAIM | 441 | Q9H892 | |
| SALCQCIAIMGNLSA | 446 | Q9H892 | |
| CMQEANASSSLCVIV | 776 | Q9UI33 | |
| MRGVSICTTCLLSVL | 96 | Q8TDU5 | |
| QSVCLSIISMLSSCK | 106 | Q96B02 | |
| SLTGFRCVVCMQTVT | 1016 | Q2M1K9 | |
| CTRSDGQNAMLSLCL | 306 | Q9C0I4 | |
| IRTLCGSLCSFSLLM | 56 | A6NGA9 | |
| LCRVSAGNDMACLTT | 466 | Q5TAX3 | |
| EVTCLTLNSLGIQMC | 2021 | P01266 | |
| CMVCGSSLATLKLST | 126 | C9JLR9 | |
| ASQCVVALSICSVEM | 801 | P49815 | |
| STTSLCNQAICMLER | 186 | Q70EL1 | |
| CVLSACPTLIALTMF | 116 | A6PVS8 | |
| AICSMCNALTTAQIV | 1766 | Q9Y4I1 |